Nexalin Technology (NXL) Other financing activities (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Other financing activities of $478611.0 in Q1 2026, down 42.44% quarter-over-quarter from $831529.0 in Q4 2025, and down 24.85% on a YoY basis from $636844.0 in Q1 2025.
Nexalin Technology (NXL) Other financing activities (2021 - 2026) Analysis & Trends
Nexalin Technology's Other financing activities history runs 6 years deep, the most recent figure standing at $478611.0 for Q1 2026.
- In Q1 2026, Other financing activities fell 24.85% year-over-year to $478611.0; the TTM figure through Mar 2026 stood at $3.0 million (down 26.54% YoY), while the FY2025 annual figure was $3.1 million, down 12.28% from the prior year.
- Other financing activities was $478611.0 for Q1 2026 at Nexalin Technology, down from $831529.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.6 million in Q3 2023 to a low of -$182721.0 in Q4 2022.
- Historically, Other financing activities has averaged $606307.4 across 5 years, with a median of $478611.0 in 2026.
- The sharpest annual moves came in 2022 and 2023: Other financing activities plunged 269.97% in 2022, then jumped 753.63% in 2023.
- A 5-year view of Other financing activities shows it stood at -$182721.0 in 2022, then soared by 960.97% to $1.6 million in 2023, then decreased by 1.36% to $1.6 million in 2024, then plunged by 46.41% to $831529.0 in 2025, then sank by 42.44% to $478611.0 in 2026.
- The last three Other financing activities figures came in at $478611.0 (Q1 2026), $831529.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 478,611.00 |
| Mar 31, 2026 | 478,611.00 |
| Dec 31, 2025 | 831,529.00 |
| Dec 31, 2025 | 831,529.00 |
| Sep 30, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 572,100.00 |
| Jun 30, 2025 | 572,100.00 |
| Mar 31, 2025 | 636,844.00 |
| Mar 31, 2025 | 636,844.00 |
| Dec 31, 2024 | 1.55 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 308,283.00 |
| Jun 30, 2024 | 308,283.00 |
| Mar 31, 2024 | 161,349.00 |
| Mar 31, 2024 | 161,349.00 |
| Sep 30, 2023 | 1.57 Mn |
| Sep 30, 2023 | 1.57 Mn |